Sanofi India Ltd — Capital/Financing Update 2020

Mar 27, 2020

==> picture [89 x 71] intentionally omitted <==

27[th] March 2020

The Secretary, The Secretary, Bombay Stock Exchange Limited, The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, 5[th] Floor, Dalal Street, Plot No. C/1, G Block, Mumbai 400 001 Bandra-Kurla Complex, Bandra East, Mumbai 400 050

Sub: Change in date for closing of transaction relating to Slump Sale and transfer of the manufacturing facility of the Company at Ankleshwar, Gujarat

Dear Sirs

This has reference to our letter dated 11[th] September 2019 wherein we intimated you that the Board of Directors of Sanofi India Limited (the Company) at its meeting held on 10[th] September 2019, approved a transaction for the slump sale and transfer of the manufacturing facility at Ankleshwar, Gujarat to Zentiva Private Limited. The closing of this transaction was subject to approval of the shareholders by way of postal ballot and certain regulatory approvals as described in the Business Transfer Agreement. It was anticipated that the closing of this transaction will be achieved on or before 31[st] March 2020 and accordingly expected closing dates were announced in disclosures to stock exchanges and postal ballot notice to the shareholders.

The shareholders of the Company approved this transaction by way of postal ballot on 30[th] October 2019.

We would like to intimate you that due to delay in receiving regulatory approvals, the closing of this transaction is not likely to be achieved by 31[st] March 2020. It is now expected that the closing of this transaction will be achieved during the quarter ending 30[th] June 2020.

This is for your information and records.

Thanking you,

Yours faithfully For SANOFI INDIA LIMITED

GIRISH ARJAN Digitally signed by GIRISH ARJAN TEKCHANDA TEKCHANDANI Date: 2020.03.27 NI 12:10:38 +05'30'

GIRISH TEKCHANDANI COMPANY SECRETARY

==> picture [532 x 15] intentionally omitted <==